Keyphrases
Pharmacogenomics
100%
Biobank
100%
Simvastatin
100%
N-acetyltransferase 2 (NAT2)
100%
Odds Ratio
50%
Cholesterol Levels
50%
Low-density Lipoprotein Cholesterol (LDL-C)
50%
Pharmacogenes
37%
European Ancestry
37%
African Ancestry
25%
Statin Therapy
25%
Interactive Effects
12%
Pharmacogenetics
12%
Medication Use
12%
Biological Mechanisms
12%
Electronic Medical Records
12%
UK Biobank
12%
Potential Gains
12%
Polygenic Risk
12%
Activity Score
12%
Absolute Risk Reduction
12%
Clinical Decisions
12%
Common Haplotype
12%
Generalized Linear Model
12%
Metabolizer Status
12%
Drug-metabolizing Enzymes
12%
Medical Genomics
12%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Pharmacogenomics
100%
Simvastatin
100%
N-Acetyltransferase 2
100%
Low-Density Lipoprotein
50%
Haplotype
25%
Statin
25%
Enzyme
12%
Allele
12%
Clinical Decision Making
12%
Risk Reduction
12%
Pharmacogenetics
12%
Electronic Medical Record
12%
Genomics
12%
Immunology and Microbiology
Pharmacogenomics
100%
Low-Density Lipoprotein
100%
Haplotype
50%
Allele
25%
Clinical Decision Making
25%
Pharmacogenetics
25%
Electronic Medical Record
25%
Neuroscience
N-Acetyltransferase
100%
Simvastatin
100%
Low Density Lipoprotein Cholesterol
50%
Haplotype
25%
Statin
25%
Clinical Decision Making
12%
Drug Metabolizing Enzyme
12%
Generalized Linear Model
12%